Valuation Indivior Pharmaceuticals, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 19:27:13 07/08/2026 +04			5-day change	1st Jan Change
38.22 ^USD	-1.16%		-4.34%	+6.68%

08-04	Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility	CI
08-04	Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,564	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	1.87%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,618	4,160	3,636
Change	-	55.81%	-17.52%	-21.95%	193.72%	0.31%	-9.92%	-12.61%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	10.4x	9.42x	8.61x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.9x	0.92x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.44x	3.35x	3.15x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.48x	3.05x	2.51x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	6.98x	6.17x	5.06x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.85x	5.95x	4.81x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	9.37x	8.42x	6.38x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	10.7%	11.9%	15.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,327	1,362	1,451
EBITDA ¹	202	225	288	338	428	661.2	673.9	718.4
EBIT ¹	187	212	269	312	415	674	698.7	755.5
Net income ¹	205	-53	2	-48	210	467	502.5	554.2
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	38.67	38.67	38.67
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	16/02/22	16/02/23	22/02/24	20/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	10.4x	3.48x	6.98x	-	4.56B
ELI LILLY AND COMPANY	33.78x	12.37x	24.91x	0.57%	1,062B
JOHNSON & JOHNSON	28.59x	-	-	2.09%	619B
ABBVIE INC.	32.06x	7.3x	15.18x	2.84%	431B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	358B
NOVARTIS AG	21.87x	5.66x	14.12x	2.84%	293B
ASTRAZENECA PLC	20.44x	4.22x	11.99x	2.09%	247B
AMGEN INC.	25.38x	6.71x	11.89x	2.49%	219B
NOVO NORDISK A/S	13.28x	4.8x	10.09x	3.83%	200B
GILEAD SCIENCES, INC.	-40.65x	5.84x	32.95x	2.52%	162B
Average	16.55x	6.13x	15.56x	2.44%	359.68B
Weighted average by Cap.	24.41x	8.10x	18.27x	2%